LDL oxidation and extent of coronary atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 2, 1998, Pages 193-199

  Van De Vijver, Lucy P L ^a,b   Kardinaal, Alwine F M ^a   Van Duyvenvoorde, Wim ^a   Kruijssen, Dick A C M ^c   Grobbee, Diederick E ^b,d   Van Poppel, Geert ^a   Princen, Hans M G ^a  

^a TNO   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Atherosclerosis; LDL composition; LDL oxidation; Propagation rate; Resistance time

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY RESISTANCE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DISEASE SEVERITY; HUMAN; LIPID COMPOSITION; LIPID OXIDATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0031809330     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.2.193     Document Type: Article

References (25)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-923.
2. Witztum JL, Steinberg D. Role of oxidative modification of LDL in atherogenesis. J Clin Invest. 1991;88:1785-1792.
3. Halliwell B. How to characterize a biological antioxidant. Free Radic Res Commun. 1990;9:1-32. Review.
4. Holvoet P, Perez G, Zhao Z, Brouwers E, Bernar H, Collen D. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease. J Clin Invest. 1995;95:2611-2619.
5. Palinski W, Horkko S, Miller E, et al. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice - demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest. 1996;98:800-814.
6. Ylä-Herttuala S, Palinski W, Rosenfeld ME, et al. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
7. Palinski W, Rosenfeld ME, Ylä-Herttuala S, et al. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989;86:1372-1376.
8. Salonen JT, Ylä-Herttuala S, Yamamoto R, et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet. 1992;339: 883-887.
9. Virella G, Virella I, Leman RB, Pryor MB, Lopes-Virella MF. Ann-oxidized low density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int J Clin Lab Res. 1993;23:95-101.
10. van de Vijver LPL, Steyger R, Van Poppel G, et al. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls. Atherosclerosis. 1996;122:245-253.
11. Regnström J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man. Lancet. 1992;339:1183-1186.
12. Cominacini L, Garbin U, Pastorini AM, et al. Predisposition to LDL oxidation in patients with and without angiographically established coronary artery disease. Atherosclerosis. 1993;99:63-70.
13. Rijke YB de, Verwey HF, Vogelezang CJM, et al. Enhanced susceptibility of low-density lipoproteins to oxidation in coronary bypass patients with progression of atherosclerosis. Clin Chim Acta. 1995;243:137-149.
14. Dieber-Rotheneder M, Puhl H, Waeg G, Striegl G, Esterbauer H. Effect of oral supplementation with D-αtocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res. 1991;32:1325-1332.
15. Princen HMG, Van Poppel G, Vogelezang C, Buytenhek R, Kok FJ. Supplementation with vitamin E but not β-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro: effect of cigarette smoking. Arterioscler Thromb. 1992;12:554-562.
16. Reaven P, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. Effect of dietary antioxidant combination in humans: protection of LDL by vitamin E but not by β-carotene. Arteriosci Thromb. 1993;13:590-600.
17. Princen HMG, Van Duyvenvoorde W, Buytenhek R, et al. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol. 1995;15:325-333.
18. Berry EM, Eisenberg S, Haratz D, Friedlander Y, Norman Y, Kaufmann NA, Stein Y. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins - the Jerusalem Nutrition Study: high MUFAs vs high PUFAs. Am J Clin Nutr. 1991;53:899-907.
19. Reaven PD, Grasse BJ, Tribble DL. Effects of linoleate-enriched and oleate-enriched diets in combination with α-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans. Arterioscler Thromb. 1994;14:557-566.
20. Hau M-F, Smelt AHM, Bindels AJGH, et al. Effects of fish oil on oxidation resistance of very low density lipoprotein in hypertriglyceridemic patients. Arterioscler Thromb Vasc Biol. 1996;16:1197-1202.
21. Bellizzi MC, Franklin MF, Duthy GG, James WPT. Vitamin E and coronary heart disease: the European paradox. Eur J Clin Nutr. 1994;48: 822-831.
22. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology. 1992;3:194-202.
23. Rimm ED, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450-1456.
24. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
25. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 1989;6:67-75.